Abstract
Takotsubo cardiomyopathy was first reported in Japan in 1990. Recently, an increasing number of case reports and reviews of takotsubo cardiomyopathy has been published worldwide, including atypical cases with inverted takotsubo cardiomyopathy or incidental coronary artery disease. To date, there has been no guideline for worldwide consensus on takotsubo cardiomyopathy diagnostic criteria and treatment. The onset mechanism of takotsubo cardiomyopathy is still controversial, although, catecholamine cardiotoxicity is considered to be the most likely cause. Here, we summarize the current case reports and reviews in regard to diagnosis, cardiac biomarkers, electrocardiogram, cardiac imaging, mechanism, treatment and prognosis in order to establish a deeper understanding of this syndrome.
Keywords: Ampulla cardiomyopathy, broken heart syndrome, catecholamine cardiotoxicity, mimicking acute myocardial infarction, neurogenic stunned myocardium, stress cardiomyopathy, transient left ventricular apical ballooning syndrome, Takotsubo cardiomyopathy, ampulla car-diomyopathy, ventriculography, subarachnoid hemorrhage, Pheochromocytoma, ventriculogram, scintigraphy, myonecrosis, electrocardiograms, computed tomography, 123-I-meta-iodobenzyl-guanidine, single-photon emission computed tomography, iodine-123-beta-methyl-p-iodophenyl pentadecanoic acid, iatrogenic, bevacizumab, paraneoplastic phe-nomena, intraaortic balloon pump-ing (IABP), prednisolone, methylprednisolone, pulmonary edema, Brain natriuretic peptide, ST-elevation myocardial infarction, Magnetic resonance imaging, Tallium-201, 18F-fluoro-deoxy-glucose, Intraventricular pressure gradient, Fragile X mental retardation-1
Current Pharmaceutical Design
Title: Takotsubo Cardiomyopathy
Volume: 16 Issue: 26
Author(s): Keisuke Kida, Yoshihiro J. Akashi, Giovanni Fazio and Salvatore Novo
Affiliation:
Keywords: Ampulla cardiomyopathy, broken heart syndrome, catecholamine cardiotoxicity, mimicking acute myocardial infarction, neurogenic stunned myocardium, stress cardiomyopathy, transient left ventricular apical ballooning syndrome, Takotsubo cardiomyopathy, ampulla car-diomyopathy, ventriculography, subarachnoid hemorrhage, Pheochromocytoma, ventriculogram, scintigraphy, myonecrosis, electrocardiograms, computed tomography, 123-I-meta-iodobenzyl-guanidine, single-photon emission computed tomography, iodine-123-beta-methyl-p-iodophenyl pentadecanoic acid, iatrogenic, bevacizumab, paraneoplastic phe-nomena, intraaortic balloon pump-ing (IABP), prednisolone, methylprednisolone, pulmonary edema, Brain natriuretic peptide, ST-elevation myocardial infarction, Magnetic resonance imaging, Tallium-201, 18F-fluoro-deoxy-glucose, Intraventricular pressure gradient, Fragile X mental retardation-1
Abstract: Takotsubo cardiomyopathy was first reported in Japan in 1990. Recently, an increasing number of case reports and reviews of takotsubo cardiomyopathy has been published worldwide, including atypical cases with inverted takotsubo cardiomyopathy or incidental coronary artery disease. To date, there has been no guideline for worldwide consensus on takotsubo cardiomyopathy diagnostic criteria and treatment. The onset mechanism of takotsubo cardiomyopathy is still controversial, although, catecholamine cardiotoxicity is considered to be the most likely cause. Here, we summarize the current case reports and reviews in regard to diagnosis, cardiac biomarkers, electrocardiogram, cardiac imaging, mechanism, treatment and prognosis in order to establish a deeper understanding of this syndrome.
Export Options
About this article
Cite this article as:
Kida Keisuke, J. Akashi Yoshihiro, Fazio Giovanni and Novo Salvatore, Takotsubo Cardiomyopathy, Current Pharmaceutical Design 2010; 16 (26) . https://dx.doi.org/10.2174/138161210793176509
DOI https://dx.doi.org/10.2174/138161210793176509 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Regulation of HIV-1 Transcription by Protein Phosphatase 1
Current HIV Research Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Radionuclide PET and PET/CT in Coronary Artery Disease
Current Pharmaceutical Design Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants
Current Drug Metabolism Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?
Current Pharmaceutical Design Patent Selections:
Recent Patents on Drug Delivery & Formulation microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Current Drug Targets Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance
Current Vascular Pharmacology Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research Gene Therapy in Cardiovascular Diseases
Current Gene Therapy Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Effect of a New Class of Compounds of the Group of Substituted 5R1, 6H2-1,3,4-thiadiazine-2-amines on the Inflammatory and Cytokine Response in Experimental Myocardial Infarction
Current Vascular Pharmacology Mechanisms Involved in Apoptosis Events Contributing to Sepsis-Induced Myocardial Dysfunction
Current Drug Therapy The LIM Protein fhlA is Essential for Heart Chamber Development in Zebrafish Embryos
Current Molecular Medicine Gender Differences in Response to Therapy for Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine